IDEXX Laboratories, Inc.

IDXX · NASDAQ

IDEXX reported FY2025 revenue of $4.3 billion and Q1 2026 revenue of $1.1 billion. The thesis depends on companion-animal diagnostics demand, instrument placement, consumables pull-through, margin durability and cash conversion.

Follow Add to Watchlist Ask Question

NASDAQ IDXX Coverage Bootstrap IDEXX Laboratories, Inc.

Latest ReportMay 20, 2026IDXX: Veterinary diagnostics quality has to keep converting into cashView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.